Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lactobacillus Acidophilus Improves the Prognosis (Cognitive Function) of Patients With Ischemic Cerebrovascular Disease After Surgery: a Multicenter, Prospective, Three-blind, Placebo-randomized Controlled Study

NCT05845983 is registered in ClinicalTrials.gov with Huaqiu Zhang as lead sponsor.

NCT NCT05845983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05845983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lactobacillus Acidophilus Improves the Prognosis (Cognitive Function) of Patients With Ischemic Cerebrovascular Disease After Surgery: a Multicenter, Prospective, Three-blind, Placebo-randomized Controlled Study
Lead sponsor
Huaqiu Zhang
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 4, 2023
Completion date
December 31, 2028
Enrollment
236 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular ischemia, cognitive impairment, ischemia